Rhythm Pharmaceuticals Inc. (RYTM)
NASDAQ · Healthcare
Rhythm Pharmaceuticals Inc. Total Liabilities 2016–2025
Rhythm Pharmaceuticals Inc. annual total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Rhythm Pharmaceuticals Inc. total liabilities as of December 31, 2025: 210.2M, a 7.71% decrease year-over-year.
- Rhythm Pharmaceuticals Inc. total liabilities for 2025 were 210.2M, a 7.71% decrease from 2024.
- Rhythm Pharmaceuticals Inc. total liabilities for 2024 were 227.7M, a 39.72% increase from 2023.
- Rhythm Pharmaceuticals Inc. total liabilities for 2023 were 163.0M, a 37.87% increase from 2022.
- Rhythm Pharmaceuticals Inc. total liabilities for 2022 were 118.2M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Rhythm Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $210 |
| 2024 | $228 |
| 2023 | $163 |
| 2022 | $118 |
| 2021 | $45 |
| 2020 | $21 |
| 2019 | $28 |
| 2018 | $14 |
| 2017 | $7 |
| 2016 | $5 |
Rhythm Pharmaceuticals Inc. Total Liabilities — FAQ
Rhythm Pharmaceuticals Inc. (RYTM) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RYTM's total liabilities history?
The chart and table above show Rhythm Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.